We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current KDGTF market cap is 674.5M. The company's latest EPS is CNY 0.0764 and P/E is 8.90.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 706.2M | 832.79M | 891.39M | 930.67M | 1.39B |
| Operating Income | 20.52M | 58.25M | 92.2M | 42.68M | 69.5M |
| Net Income | -52.67M | -169.79M | -975.78M | -1.45B | 75.46M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 576.54M | 664.42M | 1.58B | 3.19B | 3.73B |
| Total Liabilities | 1.19B | 1.46B | 3.41B | 464.15M | 871.62M |
| Total Equity | -617.92M | -799.42M | -1.83B | 2.72B | 2.85B |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 53.9M | 99.45M | 73.46M | 68.03M | 21.41M |
| Investing | -73.71M | -47.55M | -121.96M | -666.06M | -1.35B |
| Financing | -3.08M | -18.9M | 851.93M | 1.59B | 97.64M |
| Market Cap | 674.5M |
| Price to Earnings Ratio | 8.90 |
| Price to Sales Ratio | 0.48 |
| Price to Cash Ratio | 0.99 |
| Price to Book Ratio | 0.24 |
| Dividend Yield | - |
| Shares Outstanding | 987.12M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Kindstar Globalgene Technology Inc (PK) |
| Address |
p.o. box 472, 2nd floor cayman islands KY1-1106 |
| Website | https://www.kindstar.com.cn |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
